M Lenhard

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer—results at the time of surgery

Michael Untch, Peter A. Fasching, Gottfried E. Konecny et al. · Annals of Oncology · 2011 · 133 citations

Surgical Oncology, Breast Oncology, Standard-dosed Epirubicin/cyclophosphamide +9

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin–cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer—outcome on prognosis

Michael Untch, Gϋnter von Minckwitz, Gottfried E. Konecny et al. · Annals of Oncology · 2011 · 121 citations

Darbepoetin Alfa, Breast Oncology, Medicine +7

Three-dimensional pelvimetry by computed tomography

M Lenhard, T. Johnson, Sabine Weckbach et al. · La radiologia medica · 2009 · 43 citations

Computed Tomography, Engineering, Medical Imaging +7

Retinoid X receptor alpha (RXRα) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in breast cancer: an immunohistochemical study.

Nina Ditsch, Thomas Vrekoussis, M Lenhard et al. · PubMed · 2012 · 22 citations

Epoetin-alpha reduces red blood cell transfusions (RBC) in high-risk breast cancer patients with adjuvant dose-dense, sequential chemotherapy with epirubicin (E), paclitaxel (T) and cyclophosphamide (C) (ETC)

U. Michael, Christian Jackisch, M Lenhard et al. · Journal of Clinical Oncology · 2005 · 16 citations

Rbc Transfusion, Breast Cancer Pts, Oncology +14